J&J scraps COVID-19 vaccine trials in India

MARK RALSTON / AFP

Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.

That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.

While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,

The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.

More from International News

  • GCC interior ministers hold emergency meeting in Riyadh

    Interior ministers of the Gulf Cooperation Council (GCC) have held an emergency ministerial meeting in Riyadh, chaired by the Kingdom of Bahrain, according to the Saudi Press Agency.

  • Gunshots fired in standoff at Philippine Senate over ICC suspect

    Gunshots broke out in chaotic scenes at the Philippine Senate on Wednesday where troops had been deployed after a politician wanted by the International Criminal Court urged supporters to mobilise and thwart his imminent arrest.

  • Trump lands in China for Xi summit

    US President Donald Trump and an entourage that included Nvidia's Jensen Huang and Elon Musk were greeted with a lavish welcome in Beijing on Wednesday as he prepared to ask China's Xi Jinping to "open up" to US business at the start of their two-day summit.

  • Israeli airstrikes kill eight people on highway south of Beirut

    Israeli airstrikes killed eight people on a highway south of Beirut on Wednesday, Lebanon's health ministry said, as conflict between Hezbollah and Israel continued on the eve of a third round of US-mediated talks between Lebanon and Israel.

Blogs